Employing the European Thyroid Imaging Reporting and Data System 2017 classification in a malignancy risk stratification system for thyroid nodules at Can Tho Oncology Hospital from 2021 to 2023

Vo Van Kha; Tran Thi Huong Ly; Pham Thi Thanh Hoa; Vo Huynh Nhu; Damas Hendriansyah; Nusratuddin Abdullah; Rudy B. Leonardy; Mardiah Tahir; Samrichard Rambulangi; Firdaus Hamid; Filomena Pietrantonio; Vera Kopsaj; Francesco Rosiello; Aurora Tomassoni; Luca Moriconi; Donatella Padua; Kiki Rizki Amelia; Efendi Lukas; Nurbani Bangsawan; Isharyah Sunarno; Retno Budiarti Farid; Sriwijaya Qadar; Rabab H. Elshaikh; Ashok Kumar Sah; Abdelrahman Mohamed Abukanna; Abdulrahman Algarni; Ammar Abdelmola; Hussam Ali Osman; Tagwa Yousif Elsayed Yousif; Elryah I. Ali; Hiba Ali; Ayman Hussein Alfeel; Thanh Long Nguyen; Victor Storm; Lam Toi Phung; Cong Thien Le; Thi Thu Ha Le; Thi Hoa Nguyen; Son Tung Vu; Thien Thang Tran; Minh Hanh Vu; Van Tuan Nguyen; Francesco Ventrella; Anna Belfiore; Antonio Greco; Franco Mastroianni; Salvatore Lenti; Domenico Ruggiero; Michele Cannone; Vincenzo Ostilio Palmieri; Massimo Errico; Giuseppe Mancia; Guido Grassi; Sverre E. Kjeldsen

doi:10.4081/itjm.2025.1852

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Efficacy of dual therapy in patients >65 years old with alanine transaminase flare during chronic hepatitis C genotype 2

Elena Garlatti Costa, Michela Ghersetti, Silvia Grazioli, Pietro Casarin

82-88

20-03-2015

https://doi.org/10.4081/itjm.2015.471

1176

PDF: 793

HTML: 276
HBsAg loss with HBsAg/anti-HBs seroconversion and non-detectable HCV-RNA in a patient with chronic HBV e-minus/HCV hepatitis treated with two cycles of antiviral therapy

Antonio Salvio, Maria Varriale, Tito d'Errico, Gennaro De Siena, Mario Visconti

278-281

02-01-2012

https://doi.org/10.4081/itjm.2011.278

1084

PDF: 689
The management of the patient with acute pancreatitis: from evidence to clinical practice

Cristina Cenci, Tea Restuccia, Paola Gnerre, Irene Chiti, Laura Betti, Milena Micati, Claudio Tana

220-245

11-09-2017

https://doi.org/10.4081/itjm.2017.748

2687

PDF: 1176

HTML: 1339
The pharmacology and activity of non-steroidal anti-inflammatory drugs (NSAIDs): a review of their use as an adjuvant treatment in patients with HBV and HCV chronic hepatitis

Sirio Fiorino, Carmela Cursaro, Stefania Lorenzini, Elisabetta Loggi, Lucia Brodosi, Laura Cattani, Andrea Cuppini, Mauro Bernardi, Pietro Andreone

82-89

07-03-2013

https://doi.org/10.4081/itjm.2011.82

1052

PDF: 990
Genetic predictors of response to treatment of chronic hepatitis C virus infection in patients from southern Italy

Mario Masarone, Roberta Russo, Antonella Gambale, Concetta Langella, Ferdinando Carlo Sasso, Luca Fontanella, Marco Romano, Achille Iolascon, Marcello Persico

61-70

27-02-2014

https://doi.org/10.4081/itjm.2014.443

1957

PDF: 1396

HTML: 586
HCV carriers with normal aminotransferase levels: normal does not always mean healthy

Claudio Puoti

88-92

30-04-2013

https://doi.org/10.4081/itjm.2009.88

854

PDF: 1164
Compliance with the clinical practice guidelines for the management of hepatitis B and C virus-related chronic liver disease: a survey based on hospitalized cirrhotic patients

Emanuele La Spada, Giuseppe Augello, Giovanni Anastasi, Aldo Spadaro, Francesco Taormina, Felice Fiorello, Michele Stornello, Antonio Carroccio, Umberto Castiglione, Rocco Siciliano, Giuseppe Montalto, the Internal Medicine Collaborating Group

107-112

24-04-2013

https://doi.org/10.4081/itjm.2013.107

1276

PDF: 641

HTML: 326
Liver diseases and pregnancy

Pietro Crispino, Luca Fontanella, Paola Gnerre

278-287

11-09-2017

https://doi.org/10.4081/itjm.2017.817

1472

PDF: 766

HTML: 297
Use of ursodeoxycholic acid in patients with hypertransaminasemia

Claudio Puoti, Maria Giuseppa Elmo

141-147

18-09-2014

https://doi.org/10.4081/itjm.2014.426

1488

PDF: 1021

HTML: 1290
HIV, HCV and SARS-CoV-2: friends or foes? A case report

Elena Garlatti Costa, Cesare Mazzaro, Alessandro Grembiale, Alessandro Berto, Rita De Rosa, Silvia Grazioli, Maurizio Tonizzo

24-09-2021

https://doi.org/10.4081/itjm.2021.1350

963

PDF: 456

HTML: 8

1 - 10 of 10 items

Search

Search Results

Efficacy of dual therapy in patients >65 years old with alanine transaminase flare during chronic hepatitis C genotype 2

HBsAg loss with HBsAg/anti-HBs seroconversion and non-detectable HCV-RNA in a patient with chronic HBV e-minus/HCV hepatitis treated with two cycles of antiviral therapy

The management of the patient with acute pancreatitis: from evidence to clinical practice

The pharmacology and activity of non-steroidal anti-inflammatory drugs (NSAIDs): a review of their use as an adjuvant treatment in patients with HBV and HCV chronic hepatitis

Genetic predictors of response to treatment of chronic hepatitis C virus infection in patients from southern Italy

HCV carriers with normal aminotransferase levels: normal does not always mean healthy

Compliance with the clinical practice guidelines for the management of hepatitis B and C virus-related chronic liver disease: a survey based on hospitalized cirrhotic patients

Liver diseases and pregnancy

Use of ursodeoxycholic acid in patients with hypertransaminasemia

HIV, HCV and SARS-CoV-2: friends or foes? A case report

authors

reviewers

indexing

Categories

Keywords